Pandemic News and Research

RSS

A pandemic is a global disease outbreak. During a pandemic, transmission can be anticipated in the workplace, not only from patient to workers in health care settings, but also among co-workers in general work settings. A pandemic would cause high levels of illness, death, social disruption, and economic loss. Everyday life would be disrupted because so many people in so many places become seriously ill at the same time. Impacts could range from school and business closings to the interruption of basic services such as public transportation and food delivery.

Online survey launched to understand link between coronavirus restrictions and osteoarthritis risk

Researchers at Loughborough University are investigating how changes in physical activity that are a result of the global health pandemic are related to osteoarthritis development and symptoms.

22 May 2020

Scientists identify compounds in noxious weed that reduce virulence of Staphylococcus bacteria

Scientists have identified specific compounds from the Brazilian Peppertree -- a weedy, invasive shrub in Florida -- that reduce the virulence of antibiotic-resistant staph bacteria.

22 May 2020

BMA calls for extra support for doctors suffering from poor mental health and wellbeing

Almost half of doctors in England (45%) report suffering from work-related anxiety, burnout and depression, with a third of those saying this has worsened during the Covid-19 pandemic, a recent BMA survey has revealed.

22 May 2020

New review discusses findings on coronavirus immunity

A new review discusses the findings from over 40 studies on coronavirus immunity and what they could mean for the Covid-19 pandemic.

22 May 2020

Study to examine how stem cell transplant patients react to COVID-19 infection

A new study will look at how patients, who receive stem cell transplants for blood cancers and blood disorders, react to COVID-19 infection during their recovery.

22 May 2020

IL-6 blocker use in severe COVID-19 increases risk of secondary infections

With many hundreds of thousands of deaths due to the current COVID-19 pandemic, there is a rush to find an effective vaccine or drug against the virus. A new study on the preprint server medRxiv* in May 2020 shows that the use of some biologically plausible drugs may be counterproductive, and care should be taken when trying out unproven therapies.

22 May 2020

COVID-19 lockdown leads to global decline in emissions

Carbon dioxide emissions from fossil fuel sources reached a maximum daily decline of 17 per cent in April as a result of drastic decline in energy demand that have occurred during the COVID-19 pandemic.

22 May 2020

ACR warns about the economic impact of COVID-19 on rheumatology practices

In virtual meetings with lawmakers and on Twitter tomorrow, physician and health professional leaders from the American College of Rheumatology (ACR) are sounding the alarm about the economic impact of COVID-19 on rheumatology practices and the urgent need for more targeted relief that will help specialty practices remain solvent and continue to serve patients.

22 May 2020

Scientists are harnessing artificial intelligence and satellite data to predict blazes across Western US

As California and the American West head into fire season amid the coronavirus pandemic, scientists are harnessing artificial intelligence and new satellite data to help predict blazes across the region.

22 May 2020

Indica Labs and Octo announce launch of online COVID Digital Pathology Repository

Indica Labs, a leading provider of computational pathology software, and Octo, a premiere information technology systems provider to the U.S. Federal Government, are pleased to announce the online COVID Digital Pathology Repository, a virtual collection of high resolution microscopic COVID-related human tissue images hosted at the National Institutes of Health.

22 May 2020

Study evaluates the effectiveness of interferon beta 1b in COVID-19 pneumonia

As the world struggles to overcome the current COVID-19 pandemic with non-pharmacological interventions, in the absence of an effective drug or vaccine, existing immunomodulators are being repurposed. A new study published on the preprint server medRxiv* in May 2020 shows no clinical benefit to the use of one such drug, called interferon beta 1b (IFN beta1b).

22 May 2020

Preparing to meet SARS-CoV-2 head-on with a panel of neutralizing antibodies

A new study published on the preprint server bioRxiv in May 2020 describes a panel of neutralizing antibodies that bind to multiple attachment sites on the spike protein of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of the current COVID-19 disease pandemic.

22 May 2020

Prediction of incubation period for COVID-19 and other viruses

A new study published on the preprint server bioRxiv* in May 2020 provides a method to estimate the incubation period for any new pathogen, which could help to define the optimal quarantine period necessary to keep the spread of the causative agent in check.

22 May 2020

Parents lack understanding of teens' preferences for best time to talk about end-of-life decisions

The findings of a survey of adolescent cancer patients and their families at four tertiary care U.S. pediatric hospitals showed that parents had a poor understanding of their teens' preferences for the best time to bring up end-of-life decisions, dying a natural death, and being taken off life support.

22 May 2020

APA survey: High stress related to coronavirus is the new normal for many parents

Nearly half of parents of children under age 18 say their stress levels related to the coronavirus pandemic are high, with managing their kids' online learning a significant source of stress for many, according to a new survey by the American Psychological Association.

21 May 2020

ELISA and CLIA antibody tests for SARS-CoV-2 perform best in terms of sensitivity

Testing for those who have developed antibodies against the coronavirus can help tackle the ongoing COVID-19 pandemic. Now, a new study has identified all the antibody tests available for the coronavirus disease (COVID-19) to determine which performs better and is more accurate.

21 May 2020

Airway and Celonic collaborate to produce AT-100 as therapeutic candidate against COVID-19

Airway Therapeutics, Inc., a biopharmaceutical company developing a new class of biologics to break the cycle of injury and inflammation for patients with respiratory and inflammatory diseases, and Celonic Group, a premium biopharmaceutical CDMO specialized in the development and production of Advance Therapy Medicinal Products (ATMPs) and mammalian cell line-expressed biotherapeutics, today announced a collaboration to produce the novel human recombinant protein AT-100 (rhSP-D) as a therapeutic candidate against COVID-19.

21 May 2020

Pandemic News and Research

Further Reading

Online survey launched to understand link between coronavirus restrictions and osteoarthritis risk

Scientists identify compounds in noxious weed that reduce virulence of Staphylococcus bacteria

BMA calls for extra support for doctors suffering from poor mental health and wellbeing

New review discusses findings on coronavirus immunity

Study to examine how stem cell transplant patients react to COVID-19 infection

IL-6 blocker use in severe COVID-19 increases risk of secondary infections

COVID-19 lockdown leads to global decline in emissions

ACR warns about the economic impact of COVID-19 on rheumatology practices

Scientists are harnessing artificial intelligence and satellite data to predict blazes across Western US

Indica Labs and Octo announce launch of online COVID Digital Pathology Repository

Study evaluates the effectiveness of interferon beta 1b in COVID-19 pneumonia

Preparing to meet SARS-CoV-2 head-on with a panel of neutralizing antibodies

Prediction of incubation period for COVID-19 and other viruses

Parents lack understanding of teens' preferences for best time to talk about end-of-life decisions

APA survey: High stress related to coronavirus is the new normal for many parents

ELISA and CLIA antibody tests for SARS-CoV-2 perform best in terms of sensitivity

Airway and Celonic collaborate to produce AT-100 as therapeutic candidate against COVID-19

Study finds insufficient evidence to show vitamin D can prevent or treat Covid-19

New guidance to mitigate the psychological effects of social distancing

Novel tool helps translate complex communication between microbes and the body

Best practices - optimize qPCR processes for pathogen detection eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News